Loading candles…
Sanofi India Limited is a multinational pharmaceutical company operating in India within the pharmaceuticals and healthcare industries. The company focuses on medicines addressing Diabetes, Cardiology, Thrombosis, Central Nervous System disorders, and Anti-histamines. It serves as a strategic manufacturing and marketing hub for its global parent company, Sanofi. Its business segments include Diabetes Care, Cardiology, Thrombosis, Central Nervous System, Anti-histamines, and Pain Management. Sanofi India includes the subsidiary Sanofi Consumer Healthcare India Limited, which was formed as a separate entity in fiscal year 2024 following the transition of its Consumer Healthcare business. The company operates a GMP-compliant manufacturing facility in Goa and maintains a distribution network that reaches approximately 100,000 pharmacies across India.
This page is a live market overview for SANOFI INDIA LIMITED (SANOFI) on the NSE. As a listed security, SANOFI INDIA LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SANOFI before placing trades on tick2trade.
As of the latest feed, SANOFI last traded at ₹3,349.4 on NSE, down ₹3.2 (0.10%) from the previous close of ₹3,352.6. Today's session range is ₹3,320.2 – ₹3,352.9, against a 52-week band of ₹3,054 – ₹5,492. Traded volume today stands at 25.53K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for SANOFI in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SANOFI is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SANOFI INDIA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SANOFI. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SANOFI option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 4 Aug 2026 |
| Unaudited Results - FY26 | To consider and approve the unaudited financial results for the period ended March 31, 2026 | 28 Apr 2026 |
| Audited Results - Q3 & FY25 | To consider and approve the Audited Financial Results and Statements for the Quarter and Financial Year ended 31st December 2025 and Recommendation of Final … | 25 Feb 2026 |
| Unaudited Results - Q1 & FY25 | Board Meeting Intimation for consideration and approval of the Unaudited Financial Statements for the quarter and half-year ended 30th June 2025 | 31 Jul 2025 |
| Unaudited Results - Q4-FY25 | The meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 14th May 2025, inter-alia to consider and approve the Unaudited Fi… | 14 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.